Mounjaro Appears to Be Extremely Effective at Preventing Diabetes FuturismOzempic Could Prevent Diabetes. Should It Be Used for That? The New York TimesSUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity TCTMDEli Lilly's weight-loss drug helps nearly 99% of patients remain diabetes-free ReutersTreatment with tirzepatide in adults with pre-diabetes and obesity or overweight resulted in sustained weight loss and nearly 99% remained diabetes-free at 176 weeks Investors | Eli Lilly and Company